Showing results (21-30 of 506) with videos related to
Sort By:
Pageof 51
Hepatology International|March 20, 2015
Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failureMan-Fung YuenJournal of Gastroenterology and Hepatology|May 11, 2007
Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical managementMan-Fung YuenHepatology International|January 8, 2016
Need to improve awareness and management of hepatitis B reactivation in patients receiving immunosuppressive therapyMan-Fung YuenClinical and Molecular Hepatology|November 14, 2024
Prospect of emerging treatments for hepatitis B virus functional cureRex Wan-Hin Hui, Lung-Yi Mak, James Fung, et al.Expert Review of Gastroenterology & Hepatology|March 27, 2023
Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapyRex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.The American Journal of Gastroenterology|April 22, 2008
Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and managementJames Fung, Ching-Lung Lai, David But, et al.Hepatology International|June 10, 2025
Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategiesRex Wan-Hin Hui, James Fung, Wai-Kay Seto, et al.Clinical and Molecular Hepatology|January 19, 2023
The role of different viral biomarkers on the management of chronic hepatitis BLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.Hepatology International|February 17, 2025
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, et al.Expert Opinion on Investigational Drugs|October 30, 2023
Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progressLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.Pageof 51